Alvotech Sa Share Price Today
(NASDAQ: ALVO)

Name: Alvotech Sa Share Price Today (NASDAQ: ALVO) - Alvotech Sa Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Alvotech Sa share price is $12.72 & ₹1,102.06 as on 1 Feb 2025, 2.30 'hrs' IST

$12.72

▲

0.31

(2.5%)

Market is closed - opens 8 PM, 03 Feb 2025

View live Alvotech Sa share price in Dollar and Rupees. Guide to invest in Alvotech Sa stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Alvotech Sa, along with analyst recommendations, forecasts, and comprehensive financials.

Alvotech Sa share price movements

Today's Low: $12.71
Today's High: $12.93
$12.72
0.08%
Downside
Day's Volatility :1.73%
Upside
1.65%
52 Weeks Low: $9.15
52 Weeks High: $18.00
$12.72
28.07%
Downside
52 Weeks Volatility :49.17%
Upside
29.33%

Alvotech Sa (ALVO) Returns

Period	Alvotech Sa	Sector (Health Care)	Index (Russel 2000)
3 Months	-3.95%	0.3%	0.0%
6 Months	12.31%	-1.5%	0.0%
1 Year	-20.96%	5.0%	0.0%
3 Years	10.9%	12.3%	-12.8%

Alvotech Sa (ALVO) Key Statistics

in dollars & INR

Previous Close	$12.41
Open	$12.8
Today's High	$12.93344
Today's Low	$12.71
Market Capitalization	$3.8B
Today's Volume	$78.7K
52 Week High	$18.0
52 Week Low	$9.15
Revenue TTM	$308.7M
EBITDA	$-104.6M
Earnings Per Share (EPS)	$-1.85
Profit Margin	-200.3%
Quarterly Earnings Growth YOY	-0.7%
Return On Equity TTM	0.0%

How to invest in Alvotech Sa Stock (ALVO) from India?

It is very easy for Indian residents to invest directly in Alvotech Sa from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Alvotech Sa stock in both Indian Rupees (INR) and US Dollars (USD). Search for Alvotech Sa or ALVO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Alvotech Sa or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Alvotech Sa shares which would translate to 0.068 fractional shares of Alvotech Sa as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Alvotech Sa, in just a few clicks!

Returns in Alvotech Sa (ALVO) for Indian investors in Rupees

The Alvotech Sa stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Alvotech Sa investment value today

Current value as on today

₹85,438

Returns

₹14,562

(-14.56%)

Returns from Alvotech Sa Stock

₹18,981 (-18.98%)

Dollar Returns

₹4,419 (+4.42%)

Indian investors sentiment towards Alvotech Sa (ALVO)

17%

Period: Jan 1, 2025 to Jan 31, 2025. Change in 30 Days versus previous period

Search interest for Alvotech Sa Stock from India on INDmoney has increased by 17% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Alvotech Sa

Buy

72%Buy

27%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Alvotech Sa(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Alvotech Sa Stock (ALVO)

What analysts predicted

Upside of 36.79%

Target:

$17.40

Current:

$12.72

Insights on Alvotech Sa Stock (Ticker Symbol: ALVO)

Price Movement
In the last 7 days, ALVO stock has moved down by -4.5%
Decreasing Revenue
Revenue is down for the last 2 quarters, 198.75M → 102.88M (in $), with an average decrease of 48.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 65.22M → -11.39M (in $), with an average decrease of 117.5% per quarter
ALVO vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 88.6% return, outperforming this stock by 109.8%
Price to Sales
ForALVO every $1 of sales, investors are willing to pay $9.7, whereas for Intra-cellular Therapies, Inc., the investors are paying $20.8 for every $1 of sales.

ALVO Alvotech Sa Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$31.9M	-
Net Income	$-209.9M	-
Net Profit Margin	-657.55%	-

	FY20	Y/Y Change
Revenue	$66.6M	↑ 108.71%
Net Income	$-170.0M	↓ 18.98%
Net Profit Margin	-255.26%	↑ 402.29%

	FY21	Y/Y Change
Revenue	$36.8M	↓ 44.8%
Net Income	$-101.5M	↓ 40.31%
Net Profit Margin	-276.04%	↓ 20.78%

	FY22	Y/Y Change
Revenue	$83.0M	↑ 125.79%
Net Income	$-513.6M	↑ 405.97%
Net Profit Margin	-618.55%	↓ 342.51%

	FY23	Y/Y Change
Revenue	$91.4M	↑ 10.12%
Net Income	$-551.7M	↑ 7.43%
Net Profit Margin	-603.42%	↑ 15.13%

	Q2 FY23	Q/Q Change
Revenue	$4.4M	↓ 72.32%
Net Income	$189.3M	↓ 168.55%
Net Profit Margin	4.3K%	↑ 6052.6%

	Q3 FY23	Q/Q Change
Revenue	$17.8M	↑ 305.12%
Net Income	$-188.3M	↓ 199.47%
Net Profit Margin	-1.1K%	↓ 5370.31%

	Q4 FY23	Q/Q Change
Revenue	$53.4M	↑ 200.13%
Net Income	$-276.6M	↑ 46.85%
Net Profit Margin	-517.99%	↑ 540.64%

	Q1 FY24	Q/Q Change
Revenue	$12.4M	↓ 76.72%
Net Income	$-218.7M	↓ 20.91%
Net Profit Margin	-1.8K%	↓ 1241.7%

	Q2 FY24	Q/Q Change
Revenue	$198.8M	↑ 1498.98%
Net Income	$65.2M	↓ 129.82%
Net Profit Margin	32.82%	↑ 1792.51%

	Q3 FY24	Q/Q Change
Revenue	$102.9M	↓ 48.23%
Net Income	$-11.4M	↓ 117.47%
Net Profit Margin	-11.07%	↓ 43.89%

	FY19	Y/Y Change
Profit	$31.9M	-

	FY20	Y/Y Change
Profit	$66.6M	↑ 108.71%

	FY21	Y/Y Change
Profit	$36.8M	↓ 44.8%

	FY22	Y/Y Change
Profit	$18.9M	↓ 48.51%

	FY23	Y/Y Change
Profit	$-69.4M	↓ 466.65%

	Q2 FY23	Q/Q Change
Profit	$-24.4M	↑ 5.13%

	Q3 FY23	Q/Q Change
Profit	$-18.7M	↓ 23.27%

	Q4 FY23	Q/Q Change
Profit	$-3.0M	↓ 83.84%

	Q1 FY24	Q/Q Change
Profit	$-7.5M	↑ 148.5%

	Q2 FY24	Q/Q Change
Profit	$153.5M	↓ 2139.9%

	Q3 FY24	Q/Q Change
Profit	$63.1M	↓ 58.92%

	FY19	Y/Y Change
Operating Cash Flow	$-88.5M	-
Investing Cash Flow	$-12.9M	-
Financing Cash Flow	$116.4M	-

	FY20	Y/Y Change
Operating Cash Flow	$-74.3M	↓ 16.1%
Investing Cash Flow	$-16.9M	↑ 31.28%
Financing Cash Flow	$55.4M	↓ 52.39%

	FY21	Y/Y Change
Operating Cash Flow	$-228.2M	↑ 207.11%
Investing Cash Flow	$-40.6M	↑ 140.39%
Financing Cash Flow	$254.8M	↑ 359.97%

	FY22	Y/Y Change
Operating Cash Flow	$-312.4M	↑ 36.91%
Investing Cash Flow	$-63.5M	↑ 56.37%
Financing Cash Flow	$424.9M	↑ 66.74%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-41.9M	↓ 51.39%
Investing Cash Flow	$-11.4M	↑ 0.0%
Financing Cash Flow	$-2.7M	↓ 101.86%

Alvotech Sa Technicals Summary

Sell

Neutral

Buy

Alvotech Sa is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Alvotech Sa (ALVO) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Alvotech Sa	-5.7%	12.31%	-20.96%	10.9%	10.9%
Intra-cellular Therapies, Inc.	50.76%	63.24%	88.85%	164.25%	461.95%
Haleon Plc Spon Ads	1.38%	0.63%	15.16%	29.15%	29.15%
Zoetis Inc.	6.21%	-1.21%	-8.64%	-14.57%	27.44%
Neurocrine Biosciences Inc.	11.19%	3.78%	8.15%	94.65%	52.6%
Viatris Inc.	-8.05%	-1.21%	-3.63%	-25.36%	-30.11%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Alvotech Sa	55.96	NA	NA	-0.41	0.0	-0.08	NA	-3.49
Intra-cellular Therapies, Inc.	NA	NA	0.0	-0.7	-0.1	-0.07	NA	10.8
Haleon Plc Spon Ads	28.88	28.88	1.69	0.36	0.07	0.04	0.02	1.82
Zoetis Inc.	32.4	32.4	2.65	5.89	0.47	0.15	0.01	11.59
Neurocrine Biosciences Inc.	40.88	40.88	0.35	6.59	0.16	0.12	NA	26.87
Viatris Inc.	224.4	NA	0.07	2.68	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Alvotech Sa	Buy	$3.8B	10.9%	55.96	-200.3%
Intra-cellular Therapies, Inc.	Buy	$13.5B	461.95%	NA	-14.07%
Haleon Plc Spon Ads	Buy	$43.1B	29.15%	28.88	10.75%
Zoetis Inc.	Buy	$77.9B	27.44%	32.4	26.55%
Neurocrine Biosciences Inc.	Buy	$15.5B	52.6%	40.88	17.21%
Viatris Inc.	Hold	$13.5B	-30.11%	224.4	-5.87%

About Alvotech Sa

Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT04, a biosimilar to Stelara to treat various inflammatory conditions comprising psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT06, a biosimilar to Eylea to treat various conditions, such as age-related macular degeneration, macular edema, and diabetic retinopathy; and AVT03, a biosimilar to Xgeva and Prolia, which is in the pre-clinical phase to treat prevent bone fracture, spinal cord compression, and the need for radiation or bone surgery in patients with certain types of cancer, as well as prevent bone loss and increase bone mass. In addition, it offers AVT05, a biosimilar to Simponi and Simponi Aria, which is in early phase development to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and other indications; AVT16, a biosimilar to an Entyvio product; AVT23, a biosimilar to Xolair, which is in late-stage development to treat nasal polyps; and AVT33, a biosimilar to an Keytruda product. Alvotech was founded in 2013 and is based in Luxembourg, Luxembourg.

Organization	Alvotech Sa
Employees	999
CEO	Mr. Robert Wessman
Industry	Services

Management People of Alvotech Sa

Name	Title
Mr. Robert Wessman	CEO, Founder & Executive Chairman
Mr. Faysal Kalmoua	COO & Director
Mr. Joel Morales	Chief Financial Officer
Mr. Giedrius Zunda	Chief Technical Officer
Mr. Joseph E. McClellan	Chief Scientific Officer
Ms. Tanya Zharov	General Counsel
Ms. Jenny Sif Steingrimsdottir	Vice President of People & Culture
Mr. Anil Okay	Chief Commercial Officer
Mr. Ming Li	Chief Strategy Officer
Ms. Christina Siniscalchi	Chief Quality Officer

Important FAQs about investing in ALVO Stock from India :

What is Alvotech Sa share price today?

Alvotech Sa share price today stands at $12.72, Open: $12.80 ; Previous Close: $12.41 ; High: $12.93 ; Low: $12.71 ; 52 Week High: $18.00 ; 52 Week Low: $9.15.

The stock opens at $12.80, after a previous close of $12.41. The stock reached a daily high of $12.93 and a low of $12.71, with a 52-week high of $18.00 and a 52-week low of $9.15.

Can Indians buy Alvotech Sa shares?

Yes, Indians can invest in the Alvotech Sa (ALVO) from India.

With INDmoney, you can buy Alvotech Sa at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Alvotech Sa at zero transaction cost.

How can I buy Alvotech Sa shares from India?

It is very easy to buy Alvotech Sa from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Alvotech Sa (ALVO) be purchased?

Yes, you can buy fractional shares of Alvotech Sa with INDmoney app.

What are the documents required to start investing in Alvotech Sa stocks?

To start investing in Alvotech Sa, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.